175 related articles for article (PubMed ID: 36585721)
21. Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease.
Deng L; Wang T; Duan Y; Liu B; Jiang J; Liu D; Li G
Sci Rep; 2024 Jul; 14(1):15232. PubMed ID: 38956281
[TBL] [Abstract][Full Text] [Related]
22. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
23. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
[TBL] [Abstract][Full Text] [Related]
24. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
25. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y; Li H; Luo D; Jiang J; Liu B; Li G
Int Immunopharmacol; 2023 Sep; 122():110600. PubMed ID: 37423157
[TBL] [Abstract][Full Text] [Related]
26. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pretreatment prognostic nutritional index in intravenous immunoglobulin-resistant Kawasaki disease.
Li G; Xu X; Chen P; Zeng R; Liu B
Heart Vessels; 2021 Sep; 36(9):1366-1373. PubMed ID: 33686555
[TBL] [Abstract][Full Text] [Related]
28. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
31. Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease.
Liu X; Shao S; Zhang N; Wu M; Liu L; Duan H; Liu Z; Zhou K; Hua Y; Wang C
Int Immunopharmacol; 2022 Sep; 110():108986. PubMed ID: 35764015
[TBL] [Abstract][Full Text] [Related]
32. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
33. Neurological involvement in Kawasaki disease: a retrospective study.
Liu X; Zhou K; Hua Y; Wu M; Liu L; Shao S; Wang C
Pediatr Rheumatol Online J; 2020 Jul; 18(1):61. PubMed ID: 32664982
[TBL] [Abstract][Full Text] [Related]
34. Prospective Evaluation of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for Intravenous Immunoglobulin Resistance in a Large Cohort of Kawasaki Disease Patients.
Liu X; Zhou K; Hua Y; Wu M; Liu L; Shao S; Wang C
Pediatr Infect Dis J; 2020 Mar; 39(3):229-231. PubMed ID: 31917754
[TBL] [Abstract][Full Text] [Related]
35. [Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease].
Xue Y; Yin J; Xu L; Dang LH; Wang C; Cui YQ; Zhang XJ; Li CW
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1211-1218. PubMed ID: 38112137
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease.
Chidambaram AC; Ramamoorthy JG; Anantharaj A
Indian Pediatr; 2023 Mar; 60(3):207-211. PubMed ID: 36604937
[TBL] [Abstract][Full Text] [Related]
37. Verification of "Japanese Scoring Systems" to Predict IVIG Resistance and Identification of Predictors for IVIG Resistance in Thai Children with Kawasaki Disease.
Jarutach J; Roymanee S; Wongwaitaweewong K
Pediatr Cardiol; 2021 Dec; 42(8):1799-1804. PubMed ID: 34173835
[TBL] [Abstract][Full Text] [Related]
38. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
39. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
[No Abstract] [Full Text] [Related]
40. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
